RKV Medical Center Joins American Oncology Network as First Partner Practice in Oklahoma

Rhea-AI Summary

RKV Medical Center (AONC) in Muskogee, Oklahoma, joined American Oncology Network on Feb 4, 2026 as AON’s first partner practice in the state.

The partnership aims to expand access to clinical trials, advanced therapies, onsite infusion and radiation services, specialty pharmacy, centralized labs, and continued community-based care under Dr. Ravikumar Vasireddy.

Key Figures

Annual revenue: $2 billion+ Revenue growth: 40%+ year-over-year Providers: 300+ providers +5 more

8 metrics

Annual revenue $2 billion+ 12 months ended June 30, 2025 (historical growth update)

Revenue growth 40%+ year-over-year 12 months ended June 30, 2025 (historical growth update)

Providers 300+ providers Oncology and hematology across 20 states (historical growth update)

States covered 20 states Network footprint as of Aug 12, 2025 release

CMS cost savings $6 million Value-based care performance (historical growth update)

Commercial savings $2.7 million Value-based care performance (historical growth update)

Partner income uplift 30% increase Average sustainable income gain after joining AON (historical)

Clinic locations 11 locations Genesis Cancer and Blood Institute reach in Arkansas (historical news)

Market Reality Check

Price: $12.00 Vol: Volume 110 is well below ...

low vol

$12.00 Last Close

Volume Volume 110 is well below the 20-day average of 1,344, indicating light trading ahead of this announcement. low

Technical Shares at $11.50 are trading above the 200-day moving average of $8.87, and about 19.3% below the 52-week high of $14.25.

Peers on Argus

While AONC was down 4.17%, peers showed mixed moves: WHTCF at -2.44%, HWAIF at -...

While AONC was down 4.17%, peers showed mixed moves: WHTCF at -2.44%, HWAIF at -7.04%, but HLYK and NUMIF up 20.11% and 16.01%, respectively, suggesting stock-specific dynamics rather than a uniform sector move.

Historical Context

5 past events · Latest: Jan 21 (Positive)

Pattern 5 events

Date	Event	Sentiment	Move	Catalyst
Jan 21	Physician expansion	Positive	-36.6%	Genesis Cancer and Blood Institute added an endocrinologist and nurse practitioner.
Oct 10	Research presentations	Positive	-1.5%	Fifteen research abstracts accepted for ASCO Quality Care Symposium 2025.
Oct 07	Physician hire	Positive	+0.3%	AON and CCBD welcomed medical oncologist Dr. Chitra Rajagopal.
Sep 02	Physician addition	Positive	+2.8%	Genesis Cancer and Blood Institute added Dr. Beau Hilton to its team.
Aug 12	Growth update	Positive	+2.0%	Reported >$2B revenue and >40% growth with multi-state network expansion.

Pattern Detected

Recent partnership and growth announcements have often been positive in tone but have produced mixed to negative short-term price reactions.

Recent Company History

Over the past six months, American Oncology Network has repeatedly highlighted growth in its community oncology platform. On Aug 12, 2025, it reported annual revenue above $2 billion with over 40% year-over-year growth and expansion to more than 300 providers across 20 states. Subsequent updates have focused on new physicians and service lines at partner practices in Arkansas and Maryland. Despite the positive strategic trajectory, several of these upbeat announcements coincided with flat or negative next-day price moves, showing a tendency toward muted or contrary trading reactions.

Market Pulse Summary

This announcement highlights American Oncology Network’s continued expansion of its community oncolo...

Analysis

This announcement highlights American Oncology Network’s continued expansion of its community oncology platform by adding RKV Medical Center as its first Oklahoma partner. It follows prior growth milestones, including revenue above $2 billion and over 40% year-over-year growth with more than 300 providers across 20 states. Investors may track how new partnerships like RKV contribute to future scale, value-based care performance, and the sustainability of income gains reported by partner practices.

Key Terms

immunotherapy, pathology, specialty pharmacy, diagnostic imaging, +4 more

8 terms

immunotherapy medical

"Services include onsite infusion therapy, including immunotherapy; centralized laboratory..."

Treatment that uses or enhances the body’s immune system to detect and fight disease, most often cancers or chronic infections; think of it as training or arming the body’s own soldiers to find and destroy targets. It matters to investors because successful immunotherapies can lead to high-value drug approvals, recurring revenue from long-term treatments, and changes in competitive dynamics, while failures or safety issues in clinical trials can materially affect company valuations.

pathology medical

"centralized laboratory and pathology services with faster turnaround times;"

Pathology is the medical study and lab testing of disease, usually involving examination of tissue, blood, or other samples to determine what is wrong and why. For investors, pathology findings act like a forensic report for a drug, device, or diagnostic: they can confirm whether a treatment works, reveal safety issues, influence regulatory approval and market demand, and therefore affect a health‑care company’s prospects and valuation.

specialty pharmacy medical

"an in-house specialty pharmacy for timely delivery of oral cancer medications;"

A specialty pharmacy is a pharmacy that focuses on dispensing and managing high-cost, complex medications that often need special storage, handling, administration or ongoing patient monitoring—think of it as a concierge service for drugs that require extra care. Investors pay attention because these pharmacies control access, support adherence and billing for expensive treatments, which affects drug sales, reimbursement, margins and long-term revenue predictability for manufacturers and payers.

diagnostic imaging medical

"RKV also offers diagnostic imaging and radiation oncology services."

Diagnostic imaging is the use of technologies like X-rays, CT, MRI and ultrasound to create pictures of the body's internal structures so doctors can find, monitor or rule out conditions. For investors it signals where money flows in healthcare: sales of imaging machines, software, scans and related services, reimbursement rules and clinical accuracy all influence provider revenues and the pace at which new imaging products are adopted — like a camera that lets clinicians see inside a machine to diagnose problems.

radiation oncology medical

"RKV also offers diagnostic imaging and radiation oncology services."

Radiation oncology is the medical specialty that uses carefully controlled beams of radiation to shrink or destroy tumors, much like using a focused heat lamp or precise scissors to remove a problem area without cutting away healthy tissue. For investors, it matters because demand for radiation oncology drives sales of expensive machines, software, treatment services and related drugs, and is influenced by regulation, reimbursement and technological advances that can change profit potential across equipment makers, hospitals and service providers.

hematology medical

"a Board-certified medical oncologist and hematologist who has proudly served patients..."

Hematology is the branch of medicine that studies blood, its components (like red and white cells and platelets), and disorders that affect them. For investors, it matters because treatments, diagnostics, and devices that diagnose or fix blood problems can drive sales, regulatory risk, and patent value—think of it as investments in the maintenance and repair of the body's delivery system, where breakthroughs or setbacks can quickly change a company's prospects.

oncology medical

"community-based oncology practices, becoming the network’s first partner practice in Oklahoma."

Oncology is the branch of medicine focused on understanding, diagnosing, and treating cancer, including the development and testing of drugs, therapies, and screening methods. It matters to investors because advances, trial results, regulatory approvals, or setbacks in cancer research can dramatically change the value of companies and the size of potential markets—think of oncology news as weather reports that help investors steer financial decisions in a high-stakes field.

infusion therapy medical

"Services include onsite infusion therapy, including immunotherapy; centralized laboratory..."

Infusion therapy is the delivery of medicines, nutrients or fluids directly into a vein or body cavity over a set time using an IV line, pump or catheter, like a slow, controlled drip that bypasses swallowing. Investors care because it underpins durable healthcare revenue streams—hospital and home-based services, specialized equipment and drug sales—while regulatory approvals, safety issues and reimbursement rules can affect demand and margins.

AI-generated analysis. Not financial advice.

Board-certified medical oncologist and hematologist Ravikumar Vasireddy, MD, has cared for patients in the Muskogee community for more than 20 years

MUSKOGEE, Okla., Feb. 04, 2026 (GLOBE NEWSWIRE) -- RKV Medical Center (RKV), a trusted provider of cancer and blood disorder care in Muskogee and surrounding communities, today announced it has joined American Oncology Network (AON), one of the nation’s fastest-growing networks of community-based oncology practices, becoming the network’s first partner practice in Oklahoma. The practice is located at 301 N. 32^nd St. in Muskogee. Dr. Ravikumar Vasireddy is accepting new patients and can be reached at 918-683-2000.

The partnership allows RKV Medical Center to expand patient-focused services, increase access to clinical trials and advanced therapies, and pursue future growth opportunities while continuing to deliver the high-quality, compassionate care that has defined the practice for more than two decades.

RKV Medical Center is led by Ravikumar Vasireddy, MD, a Board-certified medical oncologist and hematologist who has proudly served patients in the Muskogee community for more than 20 years. As a community oncology practice, RKV provides comprehensive cancer care in a local, outpatient setting, bringing personalized, research-based treatment closer to home.

“At RKV Medical Center, our priority has always been to care for the whole person, not just the disease,” Vasireddy said. “Joining American Oncology Network allows us to strengthen that commitment by expanding access to advanced treatments and resources while preserving the personalized, community-based approach our patients know and trust.”

RKV Medical Center offers a comprehensive range of services designed to support patients physically, emotionally and financially throughout their cancer journey. Services include onsite infusion therapy, including immunotherapy; centralized laboratory and pathology services with faster turnaround times; an in-house specialty pharmacy for timely delivery of oral cancer medications; comprehensive care coordination for symptom management, nutrition and overall well-being; and dedicated financial counseling to help patients navigate coverage and access available assistance programs. RKV also offers diagnostic imaging and radiation oncology services.

By combining specialty expertise with care delivered close to home, RKV Medical Center remains committed to providing a compassionate, patient-centered experience for every individual it serves.

Vasireddy earned his medical degree from Kakatiya University in Warangal, India, where he also completed a residency in pathology. He later completed a dermatology residency at Osmania University in Hyderabad, India, followed by an internal medicine residency at Prince George’s Hospital in Cheverly, Maryland. He completed his fellowship in medical oncology and hematology at the University of Cincinnati in Ohio. Vasireddy is certified by the American Board of Internal Medicine and licensed by the Oklahoma State Medical Board. His clinical interests include lung cancer, breast cancer, multiple myeloma, lymphoma and colon cancer.

“We are pleased to welcome RKV Medical Center to American Oncology Network,” said Todd Schonherz, chief executive officer of AON. “Dr. Vasireddy’s longstanding dedication to delivering high-quality, personalized cancer care in the community strongly aligns with AON’s mission. This partnership enhances our presence in Oklahoma and reinforces our commitment to increasing access to community-based oncology care.”

“Dr. Vasireddy has built a respected practice centered on clinical excellence and patient trust,” said Stephen “Fred” Divers, MD, chief medical officer of AON. “His expertise and collaborative approach will be a valuable addition to our network as we continue advancing high-quality community oncology care.”

For more information about American Oncology Network, visit AONcology.com. To learn more about RKV Medical Center, visit rkvmedicalcenter.com.

About RKV Medical Center
RKV Medical Center is a community-based medical oncology and hematology practice serving Muskogee, Oklahoma, and surrounding areas for more than 20 years. The practice specializes in the diagnosis and treatment of cancer and blood disorders and is dedicated to providing compassionate, patient-centered care throughout every stage of the healthcare journey. For more information, please visit rkvmedicalcenter.com.

About American Oncology Network
American Oncology Network (AON) is an alliance of physicians and seasoned healthcare leaders partnering to ensure the long-term success and viability of community oncology and other specialties. Founded in 2018, AON’s rapidly expanding network represents more than 300 providers practicing across 21 states. AON pioneers innovative healthcare solutions through its physician-led model, fostering value-based care that improves patient outcomes while reducing costs and expanding access to quality care. AON equips its network physicians with the tools they need to thrive independently while providing comprehensive support, integrated revenue-diversifying ancillary services, and practice management expertise, enabling physicians to focus on what matters most – providing the highest standard of care for every patient. AON is committed to promoting health equity by addressing disparities in cancer care and ensuring that all patients have access to the care they need to achieve optimal health outcomes. With a focus on innovation and collaboration, AON is shaping the future of community oncology. For more information, please visit AONcology.com or follow us on LinkedIn, Facebook, X (formerly Twitter) and YouTube.

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/3af5b0d9-f3e9-4dcc-8f2e-44717011b1b6

Media Contact:
Karen Riley Sawyer
American Oncology Network
Karen.Sawyer@AONcology.com

FAQ

What does RKV Medical Center joining American Oncology Network (AONC) mean for Muskogee patients?

It expands local access to advanced cancer care and clinical trials for Muskogee patients. According to American Oncology Network, the partnership brings expanded trial access, onsite infusion, specialty pharmacy services, centralized labs, and care coordination while preserving community-based personalized treatment.

How can new patients schedule care with Dr. Ravikumar Vasireddy at RKV Medical Center (AONC)?

New patients can schedule appointments directly with the practice by phone at the listed Muskogee number. According to RKV Medical Center, Dr. Vasireddy is accepting new patients and can be reached at 918-683-2000 for evaluations and referrals.

Which services will RKV Medical Center provide after joining AON (AONC)?

RKV will continue offering infusion therapy, immunotherapy, radiation, imaging, and in-house specialty pharmacy. According to RKV Medical Center, services also include centralized lab/pathology, care coordination, nutrition support, and financial counseling for patients.

Why is RKV Medical Center’s partnership with American Oncology Network significant for AON (AONC)?

It marks AON’s first partner practice in Oklahoma, expanding regional reach and community oncology presence. According to American Oncology Network, the addition strengthens local access to network resources and collaborative clinical expertise in Oklahoma.